In a similar vein, recent work has revealed that TGF-β and Smad4 could induce Fscn1 overexpression in basal-like breast cancer cells by directly binding to a Smad-binding element on the Fscn1 promoter (ref. 56). This evidence concerns the gene SMAD4 and breast cancer.